 |
|
Home | Research Analysts’ Downgrades for May, 8th (ALNY, BTVCY, CHK, CPA, GOL, HAIN, HANS, PRO, REGN, SMI) |
 |
Research Analysts’ Downgrades for May, 8th (ALNY, BTVCY, CHK, CPA, GOL, HAIN, HANS, PRO, REGN, SMI)
|
 |
- May 10, 2015
-
Research Analysts’ downgrades for Friday, May 8th: Alnylam Pharmaceuticals (NASDAQ:ALNY) was downgraded by analysts at Zacks from a buy rating to a hold rating. Zacks’ analyst wrote, “Alnylam’s first-quarter results were encouraging with the company posting a narrower loss and higher revenues compared to the year-ago period. Alnylam’s collaborations with several leading health care companies […]This article (Research Analysts’ Downgrades for May, 8th (ALNY, BTVCY, CHK, CPA, GOL, HAIN, HANS, PRO, REGN, SMI)) was originally developed by and is property of American Banking News.
Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.
- Read more at:http://www.americanbankingnews.com/2015/05/08/research-analysts-downgrades-for-may-8th-alny-btvcy-chk-cpa-gol-hain-hans-pro-regn-smi/
- Teen who got into all 8 Ivy League schools picks Yale
- Investment Analysts’ Ratings Reiterations for May, 8th (AMEC, AV, BAESY, BLK, BRGYY, BSY, BT, CPYYY, CYBR, EXPGY)
- Can You Beat Tiger Woods?
- 20-somethings are actually saving for retirement
|
 |
|
 |
|
 |
